Application of daytime neuroimmunotherapy bed model in patients with autoimmune diseases of the nervous system
10.3760/cma.j.cn211501-20240406-00803
- VernacularTitle:日间神经免疫治疗病床模式在神经系统自身免疫性疾病患者中的应用
- Author:
Jinhua CHEN
1
;
Jing LI
;
Yaying MA
;
Xiaofei WU
;
Meiqi YAO
Author Information
1. 浙江大学医学院附属第二医院护理部，杭州 310000
- Keywords:
Autoimmune diseases of the nervous system;
Rituximab;
Optimize the process;
Daycare;
Multidisciplinary team
- From:
Chinese Journal of Practical Nursing
2024;40(25):1940-1945
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the application effect of the daytime neuroimmunotherapy bed model in patients with autoimmune diseases of the nervous system.Methods:The quasi-experiment research method was adopted, with the implementation time of the new procedure as the dividing point, 96 patients from November 1, 2020 to October 31, 2022 were selected as the control group, and routine management procedures was adopted.64 patients from November 1, 2022 to October 31, 2023 were selected as the experimental group, and the optimized management process was applied, the intervention effects of the two groups were compared.Results:There were 69 females and 27 males with (39.5 ± 1.4) years old in the control group, 44 females and 20 males with (39.9 ± 1.4) years old in the experimental group. Waiting time for bed, admission time to start medication, length of hospital stay, incidence of adverse drug reactions, timely follow-up rate and patient satisfaction in the experimental group were (24.3 ± 10.6) h, (4.5 ± 1.4) h, (18.9 ± 17.2) h, 4.7%(3/64), 96.9%(62/64) and (99.50 ± 1.14) points, while the control group were (105.3 ± 35.2) h, (36.1 ± 18.7) h, (78.3 ± 63.8) h, 14.6%(14/96), 82.3%(79/96) and (95.74 ± 2.39) points, there were statistical significance between the two groups ( t=2.41-21.17, χ2=7.80, 3.96, all P<0.05). Conclusions:The optimized daytime neuroimmunotherapy bed model can effectively shorten the patients′ bed waiting time, admission time to start medication, and length of hospital stay, reduce the incidence of adverse drug reactions, and improve the timely follow-up rate and patient satisfaction.
